[{"address1": "91 43rd Street", "address2": "Suite 110", "city": "Pittsburgh", "state": "PA", "zip": "15201", "country": "United States", "phone": "(412) 432-1500", "website": "https://www.predictive-oncology.com", "industry": "Medical Instruments & Supplies", "industryKey": "medical-instruments-supplies", "industryDisp": "Medical Instruments & Supplies", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Predictive Oncology Inc., a science-driven company that applies artificial intelligence to support the discovery and development of optimal cancer therapies. It operates through three segments: Pittsburgh, Birmingham, and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of approximately 150,000 tumor samples and creates proprietary 3D culture models used in drug development. The Birmingham segment offers contract services and research focused on solubility improvements, stability studies, and protein production. The Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It has collaboration agreement with FluGen in development of intranasal flu vaccine, currently under Phase 2B trails. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Pittsburgh, Pennsylvania.", "fullTimeEmployees": 34, "companyOfficers": [{"maxAge": 1, "name": "Mr. Raymond F. Vennare", "age": 70, "title": "CEO & Chairman", "yearBorn": 1953, "fiscalYear": 2023, "totalPay": 525000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joshua  Blacher M.B.A.", "age": 50, "title": "Interim Chief Financial Officer", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Theresa  Ferguson", "title": "Senior Director of Marketing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lawrence J. DeLucas D.Sc, O.D, Ph.D.", "title": "Senior Vice President of Biologics", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Arlette H. Uihlein FCAP, M.D.", "title": "Senior VP of Translational Medicine & Drug Discovery and Medical Director", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.81, "open": 1.73, "dayLow": 1.68, "dayHigh": 1.86, "regularMarketPreviousClose": 1.81, "regularMarketOpen": 1.73, "regularMarketDayLow": 1.68, "regularMarketDayHigh": 1.86, "beta": 1.29, "forwardPE": -14.666667, "volume": 211483, "regularMarketVolume": 211483, "averageVolume": 172266, "averageVolume10days": 891510, "averageDailyVolume10Day": 891510, "bid": 1.67, "ask": 1.82, "bidSize": 100, "askSize": 100, "marketCap": 7150616, "fiftyTwoWeekLow": 1.12, "fiftyTwoWeekHigh": 7.12, "priceToSalesTrailing12Months": 4.01699, "fiftyDayAverage": 2.2362, "twoHundredDayAverage": 3.25025, "currency": "USD", "enterpriseValue": 1279567, "floatShares": 3596844, "sharesOutstanding": 4062850, "sharesShort": 12980, "sharesShortPriorMonth": 11050, "sharesShortPreviousMonthDate": 1710460800, "dateShortInterest": 1713139200, "sharesPercentSharesOut": 0.0032, "heldPercentInsiders": 0.03551, "heldPercentInstitutions": 0.09104, "shortRatio": 0.44, "shortPercentOfFloat": 0.0033000002, "impliedSharesOutstanding": 4178280, "bookValue": 2.036, "priceToBook": 0.8644401, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -13983967, "trailingEps": -3.48, "forwardEps": -0.12, "lastSplitFactor": "1:20", "lastSplitDate": 1682294400, "enterpriseToRevenue": 0.719, "enterpriseToEbitda": -0.097, "52WeekChange": -0.46607667, "SandP52WeekChange": 0.24486005, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "POAI", "underlyingSymbol": "POAI", "shortName": "Predictive Oncology Inc.", "longName": "Predictive Oncology Inc.", "firstTradeDateEpochUtc": 1272893400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "ede503d8-4ee2-3426-a158-08a863c76bc5", "messageBoardId": "finmb_50261774", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.76, "recommendationMean": 2.0, "recommendationKey": "buy", "totalCash": 8728660, "totalCashPerShare": 2.148, "ebitda": -13182012, "totalDebt": 2856814, "quickRatio": 2.294, "currentRatio": 2.551, "totalRevenue": 1780093, "debtToEquity": 34.537, "revenuePerShare": 0.443, "returnOnAssets": -0.4334, "returnOnEquity": -0.9311, "freeCashflow": -8528935, "operatingCashflow": -13189390, "revenueGrowth": -0.078, "grossMargins": 0.64338994, "operatingMargins": -10.464499, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-05-07"}]